At the recent AACR Conference on Pancreatic Cancer, Kevan M. Shokat, PhD, FAACR, received the 2026 Stephenson Global Prize...
Yet more good news emanated from the U. S. Food and Drug Administration (FDA) last week when it announced...
The American Association for Cancer Research is thrilled to announce its 2015 class of fellows of the AACR Academy....
A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have...
Guest Post by Peter A. Jones, PhD, DSc Research Director and Chief Scientific Officer Van Andel Research Institute
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new treatments for cancer continued last week...
When the hottest minds in cancer genomics meet the hottest minds in computational and systems biology, you can rest...
Last week, the U.S. Food and Drug Administration (FDA) announced the first-ever approval of a treatment for Waldenström macroglobulinemia,...
Wednesday is World Cancer Day. This international initiative of the Union for International Cancer Control (UICC) takes place every...
A recent study in the AACR’s journal Cancer Epidemiology, Biomarkers & Prevention suggests that different types of cancer fear...
Big progress was made in 2014, in the form of FDA approvals for new immunotherapies, targeted therapies, and a...